Pharmaceuticals Partner To Expand Access To Quality Healthcare

CHI Pharmaceuticals, a member of the Tropical General Investment (TGI) Group, and EVA Pharma, a leading global healthcare solutions provider operating in over 70 countries, recently announced a strategic partnership to expand access to essential medicines for patients in Nigeria.

This partnership will leverage CHI Pharmaceuticals’ local expertise and EVA Pharma’s extensive portfolio ‒ covering more than ten therapeutic areas ‒ to address pressing patients’ needs.

The recent collaboration covers metabolic health, diabetes, and virology, especially hepatitis B.
EVA Pharma and CHI Pharmaceuticals unveiled this collaboration at an event held at CHI Pharmaceuticals’ headquarters in Lagos, Nigeria. EVA Pharma’s Nigeria Country Manager, David Otokpa, and the Marketing Lead of West Africa, Bishoy Faltas, attended the event.

Following the shared capacity-building mission, the event included an onboarding session to familiarise CHI Pharma’s personnel with EVA Pharma’s broad product portfolio.

Shriram Iyer, Chief Operating Officer (COO) of CHI Pharmaceuticals, highlighted the strategic alignment between both companies in their vision to improve healthcare outcomes in Nigeria.

“We are excited to collaborate with EVA Pharma, a company renowned for its innovative approach and patient-centric solutions. This partnership demonstrates our ongoing commitment to providing Nigerians with high-quality and affordable healthcare products,” said Iyer. “With this alliance, we are expanding our reach and strengthening our healthcare services, enabling us to meet the healthcare needs of millions of Nigerians.”

Bishoy Faltas, Marketing Lead for West Africa at EVA Pharma, described the recent collaboration as a significant milestone in our ongoing mission to support all African communities by providing innovative and accessible healthcare solutions.

We hope Nigerian patients will benefit from available and affordable life-saving medicines, contributing to their overall health and well-being.”

Dr Sylvia Vito, Head of Sub-Sahara Africa at EVA Pharma, noted the importance of the collaboration: “We are deeply committed to improving access to essential healthcare across the Sub-Sahara region through partnerships and collaborations with local and regional companies and entities to ensure that life-saving treatments reach patients.”

Both parties reaffirmed their commitment to advancing this partnership, which is expected to enhance sustainable access to essential medicines in Nigeria significantly, ultimately improving citizens’ health and well-being.